FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP

2. Date of Event Requiring Statement (MM/DD/YYYY)
12/19/2008 

3. Issuer Name and Ticker or Trading Symbol

ATS MEDICAL INC [ATSI]

(Last)        (First)        (Middle)

21 WATERWAY AVENUE, SUITE 225

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

THE WOODLANDS, TX 77380       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   7712766   (1) D    
Common Stock   556093   (1) I   Essex Woodlands Health Ventures Fund VIII-A, L.P.   (3)
Common Stock   241780   (1) I   Essex Woodlands Health Ventures Fund VIII-B, L.P.   (3)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant   12/19/2008   12/19/2015   Common Stock   2313830   (1)   (2) D    
Warrant   12/19/2008   12/19/2015   Common Stock   166828   (1)   (2) I   Essex Woodlands Health Ventures Fund VIII-A, L.P.   (3)
Warrant   12/19/2008   12/19/2015   Common Stock   72534   (1)   (2) I   Essex Woodlands Health Ventures Fund VIII-B, L.P.   (3)

Explanation of Responses:
( 1)  Relects an internal rebalancing of shares and warrants among the funds.
( 2)  Warrants are exercisable at a price of $2.475 per share during the first year, $2.85 per share during the second year, and $3.10 thereafter.
( 3)  The general partner of the reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of the pecuniary interest therein.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
ESSEX WOODLANDS HEALTH VENTURES FUND VIII LP
21 WATERWAY AVENUE
SUITE 225
THE WOODLANDS, TX 77380
X


Signatures
/s/ Martin P. Sutter, Manager of Essex Woodlands Health Ventures VIII, LLC, the General Partner of the General Partner of Essex Woodands Health Ventures Fund VIII, L.P. 6/8/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Ats Medical (MM) (NASDAQ:ATSI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Ats Medical (MM).
Ats Medical (MM) (NASDAQ:ATSI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Ats Medical (MM).